PAX3 and sarcoma: Kras-expressing tumors were also enriched for gene sets specific to undifferentiated pleomorphic sarcomas (ES = 0.82, p < 0.001, Figure 4D) and myogenic targets of the ARMS specific transcription factor PAX3-FOXO1 (ES = 0.77, p < 0.01, Figure 4E).